Blog Posts

Former 340B Health, Evernorth Executives Join Walgreens 

Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California, Texas, Oklahoma Advance 340B Contract Pharmacy Access Bills with Key Amendments

California lawmakers recently advanced a 340B contract pharmacy access bill through committee but amended it to exclude 340B hospitals.
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe

U.S. Sen. Bill Cassidy (R-La.) laid out a series of potential policies Congress could adopt to “bring much-needed reform to the 340B program” in a 195-page report, which summarized the findings of the investigation he launched in 2023—as the HELP panel’s top Republican—into how certain hospitals, health centers, chain pharmacies and drugmakers operate their 340B programs.
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in Early 2025, Filings Show

Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Indiana Legislature Passes Sweeping 340B Hospital Reporting Bill, Sends to Gov. Braun

Both chambers of the Indiana legislature on April 23 passed a 340B hospital reporting bill.
Indiana lawmakers yesterday overwhelmingly approved a bill that would require state hospitals to annually report extensive financial and operational information [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Appellate Court Briefings on 340B Laws in West Virginia, Louisiana

Key briefs were filed recently in state contract pharmacy litigation in two federal appeals court.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm, founded by industry veteran Mesfin Tegenu, is dedicated to developing technology solutions that streamline the drug supply chain and

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live